In sum, our study is the first to report that targeting PFKFB3 using its selective antagonist PFK15 not only halts the cell proliferation of HNSCC cells but also impairs their motilities for distant metastasis. This evidence concerns the gene PFKFB3 and head and neck squamous cell carcinoma.